End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.35 USD | 0.00% | -0.15% | +16.29% |
Apr. 30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.29% | 3.77B | |
+42.54% | 50.93B | |
-0.45% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.99% | 26.02B | |
-21.91% | 18.9B | |
+7.49% | 13.21B | |
+24.20% | 12.17B | |
+29.99% | 12.16B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Barclays Initiates Alvotech With Equalweight Rating, Price Target is $10